Soy Isoflavones Market Synopsis

Soy Isoflavones Market Size is Valued at USD 17.2 Billion in 2023, and is Projected to Reach USD 37.65 Billion by 2032, Growing at a CAGR of 14.19% From 2024-2032.

The soy isoflavones market deals with the supply chain including manufacturer, supplier and consumer end products of isoflavones which are compounds found in soy beans with estrogen like properties benefits to the human body. These compounds are recognised in nutraceuticals, functional foods and drinks, thus fulfilling the consumers’ demand for natural products for hormones replacement, menopause symptoms, and general wellbeing. The market is pulled by boosting awareness of health benefits by soy isoflavones, growing demand for plant-base food products, and changing trends towards preventive healthcare. Further, the market has drivers like the increasing customer focus on natural products and the growing studies on isoflavones for a variety of ailments.

  • The market of soy isoflavones is expected to experience steady growth in the near future due to consumers’ growing concern about the health effects of these substances. Isoflavones are phytoestrogens made mostly from soy; they work like estrogen in the body providing numerous associated health benefits including hormone regulation, menopausal signs and symptoms, and possibly anti-cancer properties. This has prompted organizations preparing products that will help to manage such diseases such as osteoporosis and breast cancer such as products made of soy isoflavones that act as dietary supplements and functional foods. Due to peoples’ increasing level of health consciousness, the incorporation of these isoflavones in food and beverages is gradually applause.
  • North America And Europe are two leading market areas due to health and wellness-oriented culture as well as the focus on preventive measures. In these regions, growing trends for ever-popular plant-based diets and purchase of soy products by the improving health-conscious population have boosted the market. However, Asia-Pacific is considered a potential market as it has a large population and becoming aware of the health efficiency of soy isoflavones. Due to traditional consumption of soy products in the region as the diets of local consumers have equally shifted more towards soy products, demand is anticipated to increase.
  • However, it is not all rosy going by the following challenges that Soy isoflavones faces; prices of raw materials and regulatory nature are always unpredictable. However, other sources containing plant-based proteins and other food supplements pose threats to the market. Therefore, the major players in the industry are directing their efforts towards product differentiation and increasing the availability of their products to the consumer. In conclusion, the market of soy isoflavones is promising, because of the prospects of health and consumer preferences for natural and functional additive.

Soy Isoflavones Market Trend Analysis

Alleviating Menopausal Symptoms and Supporting Overall Wellness

  • Soy isoflavones are being promoted for increasing estrogen like effects and can go a long way in managing some of the symptoms associated with the menopause such as hot flushes, sweating at night, and mood swings. This has made them preferred by women who prefer natural products to HRT (Hormone Replacement Therapy) products. According to another study, soy isoflavones might help rectify hormonal shift, which is claimed to be less hazardous and more organic compared to some drugs used to treat menopausal symptoms. Since the public becomes aware of the possibility of side effects arising from the utilization of synthetic HRT, more women are now using dietary supplements and functional foods with high concentrations of soy isoflavones as better alternatives to promoting well-being during this menopausal period.
  • Soy isoflavones are known to have positive effects on bone and heart health besides the improtant role of trea ting menopausal symptoms in women. Some research has indicated that these compounds naturally may raise bone mineral content, lowering the likelihood of osteoporosis, an issue that tends to worsen with age. In addition, there are actually certain phytoestrogens in soy that seem to reduce the LDL cholesterol levels and up the HDL cholesterol levels in the body, all of which works towards enhancing heart health. This twofold use makes soy isoflavones a suitable component in a vast number of products, carrying the Health Claims, starting from dietary supplements, through modifications of the food products, up to beverages appealing to the contemporary consumers interested in their health.

The Rise of Plant-Based Diets: Fueling the Demand for Soy Isoflavones

  • By moving towards a vegetarian and vegan diet, people’s growing interest in plant-based nutrition is driving the growth of the soy isoflavones market more and more. All these dietary practices are incumbent on factors mainly considering health concerns, environmental problems and animal suffering. Therefore, end-consumers are in the hunt for protein and other nutrients from plant sources, and, among soy products, which are packed with protein and numerous phytonutrients like the isoflavones. This increasing demand is not only with conventional soy foods like tofu and edamame; but consumers are much more willing to try new types of food formulations that contain soy isoflavones, there is an easier way of including such plethora of nutritional benefits in the diets.
  • Subsequently, food manufacturer companies are now designing better and more attractive food products containing soy isoflavones. Fortification has recently led to the emergence of new products such as fortified alcoholic and non-alcoholic beverages, snack bars, prostate smoothies, and any product in between that feeds the ever-growing demand for convenient, healthy foods. Also, the growing demand for organic and non-Gene-Modified products also boosts this market growth, and the fulfillment of a consumer trend that demands such products due to their natural health benefits and sustainability. These overlaps of consumers’ preferences are making the later market highly vibrant with soy isoflavones forming the basis of many foods that are marketed in the health sector. Growing health concern and understanding of soy products has made the soy isoflavones market profound for a steady market and constant development.

Soy Isoflavones Market Segment Analysis:

Soy Isoflavones Market Segmented based on By Raw-material type, By application and By product type

By Raw-material type, Genetically Modified (GM) segment is expected to dominate the market during the forecast period

  • GM soybeans have become popular in the agricultural market because of their improved attributes such as pests’ tolerance and productivity. Such changes also contribute to increased yield, but, in addition, they minimize crop damage by pests and diseases. For this reason, GM soy offers a cheaper input and is well suited for use by companies that need to cut down on costs while improving efficiency.
  • Consumers and producers are increasingly embracing GM products due to increasing concern of food security, and the imperative to practice modern and sustainable farming. GM soy is considered by many stakeholders as a response to issues raised by increased population and dynamic climate, thus the versatility of applications of the product in food, drinks and medicinal supplements. This acceptance is further supported by legislation that guarantees the suitability of GMO foods and other crops to the market adding to a favourable setting for the expansion of GMO farms in several segments.

By product type, Genistein segment held the largest share in 2023

  • Genistein is another isoflavone from soy which has been praised for its health benefits including being an antioxidant and you could also say it might prevent some kinds of cancer. This bioactive compound has thus garnered interest in relation to health status and thus applied in supplements and functional foods. People with healthy interest are in particular being attracted to genistein products because they want to make the right choices that will benefit their health.
  • A considerable number of scientific articles indicates that genistein works indeed, including to reduce the signs of menopause, hot flashes, and temper fluctuations. It has placed genistein as a preferable alternative for women with hormonal fluctuations and this has made it to gain more marketability. Furthermore, it is packing a lot of values that relate to cardiovascular and bone health, making it quite suitable for almost any consumer group. As the word spreads about the use of genistein for these health benefits, its uses will likely extend even further in the product market, hence more place in the future.

Soy Isoflavones Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • Soy isoflavones products have experienced an even higher increase in North America especially United States due to increased awareness on plant protein and healthy living. Indeed, a number of customers are always looking for natural products and remedies for different complaints, including the use of soy isoflavones that can help in controlling of menopausal problems inclusive of hot flashes and mood swings. This demographic transition is specially seen in middle women of child bearing age group who take food supplements that imitated the soy isoflavones as safe and effective than the hormone replacement therapies. Moreover, the use of soy isoflavones in a variety of food and non-food products such as protein bars, juice and smoothies are characteristic of the effort exhibited by the already established food industry players to capture this type of consumer.
  • Furthermore, a huge scientific evidence has persisted to suggest the many health advantageous benefits of soy isoflavone making it even more marketable in the North American region. Research conducted on them has suggested that they can help prevent hormone dependent cancers such as breast and prostate cancer, and assist with heart condition through effecting changes in the cholesterol levels and vascular health. From this increasing number of studies, not only individual consumers have benefited but producers have also been forced to make claims regarding the presence of soy isoflavones in their products As. Consequently as consumers become aware of the various health benefits associated with soy isoflavones, the market for soy isoflavones is likely to grow in the future with an increasing demand from the consumer as well as innovation from industries, functional foods as well as dietary supplements.

Active Key Players in the Soy Isoflavones Market

  • Frutarom Health (SoyLife);
  • Archer Daniels Midland Company (ADM);
  • Koninklijke DSM N.V. (DSM);
  • SunOpta Inc.;
  • BASF SE;
  • Cargill Inc.,
  • Novogen Limited;
  • E. I. du Pont de Nemours and Company
  • Other Key Players

Global Soy Isoflavones Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 17.2 Bn.

Forecast Period 2024-32 CAGR:

14.19 %

Market Size in 2032:

USD 37.65 Bn.

Segments Covered:

By Raw-material type

  • Genetically Modified (GM)
  • Non-Genetically Modified (Non-GM) Soy

By application

  • Soy-Beverages
  • Functional Foods
  • Healthcare Products
  • Dietary
  • Menopausal
  • Bone Health
  • Others Supplements

By product type

  • Genistein
  • Daidzein
  • Glutenin

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Awareness

Key Market Restraints:

  • Allergic Reactions

Key Opportunities:

  • Innovative Applications

Companies Covered in the report:

  •  Frutarom Health (SoyLife); Archer Daniels Midland Company (ADM); Koninklijke DSM N.V. (DSM); SunOpta Inc.; BASF SE; Cargill Inc., Novogen Limited; E. I. du Pont de Nemours and Company and Other Major Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Soy Isoflavones Market by Raw-material type
 4.1 Soy Isoflavones Market Snapshot and Growth Engine
 4.2 Soy Isoflavones Market Overview
 4.3 Genetically Modified (GM) Soy
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Genetically Modified (GM) Soy: Geographic Segmentation Analysis
 4.4 Non-Genetically Modified (Non-GM) Soy
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Non-Genetically Modified (Non-GM) Soy: Geographic Segmentation Analysis

Chapter 5: Soy Isoflavones Market by Application
 5.1 Soy Isoflavones Market Snapshot and Growth Engine
 5.2 Soy Isoflavones Market Overview
 5.3 Soy-Beverages
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Soy-Beverages: Geographic Segmentation Analysis
 5.4 Functional Foods
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Functional Foods: Geographic Segmentation Analysis
 5.5 Healthcare Products
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Healthcare Products: Geographic Segmentation Analysis
 5.6 Dietary Supplements
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Dietary Supplements: Geographic Segmentation Analysis
 5.7 Menopausal Supplements
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Menopausal Supplements: Geographic Segmentation Analysis
 5.8 Bone Health Supplements
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Bone Health Supplements: Geographic Segmentation Analysis

Chapter 6: Soy Isoflavones Market by Product type
 6.1 Soy Isoflavones Market Snapshot and Growth Engine
 6.2 Soy Isoflavones Market Overview
 6.3 Genistein
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Genistein: Geographic Segmentation Analysis
 6.4 Daidzein
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Daidzein: Geographic Segmentation Analysis
 6.5 Glutenin.
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Glutenin.: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Soy Isoflavones Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 FRUTAROM HEALTH (SOYLIFE)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ARCHER DANIELS MIDLAND COMPANY (ADM)
 7.4 KONINKLIJKE DSM NV (DSM)
 7.5 SUNOPTA INC
 7.6 BASF SE
 7.7 CARGILL INC
 7.8 NOVOGEN LIMITED
 7.9 EI DU PONT DE NEMOURS AND COMPANY
 7.10 OTHER ACTIVE PLAYERS

Chapter 8: Global Soy Isoflavones Market By Region
 8.1 Overview
8.2. North America Soy Isoflavones Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Raw-material type
  8.2.4.1 Genetically Modified (GM) Soy
  8.2.4.2 Non-Genetically Modified (Non-GM) Soy
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Soy-Beverages
  8.2.5.2 Functional Foods
  8.2.5.3 Healthcare Products
  8.2.5.4 Dietary Supplements
  8.2.5.5 Menopausal Supplements
  8.2.5.6 Bone Health Supplements
  8.2.6 Historic and Forecasted Market Size By Product type
  8.2.6.1 Genistein
  8.2.6.2 Daidzein
  8.2.6.3 Glutenin.
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
8.3. Eastern Europe Soy Isoflavones Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Raw-material type
  8.3.4.1 Genetically Modified (GM) Soy
  8.3.4.2 Non-Genetically Modified (Non-GM) Soy
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Soy-Beverages
  8.3.5.2 Functional Foods
  8.3.5.3 Healthcare Products
  8.3.5.4 Dietary Supplements
  8.3.5.5 Menopausal Supplements
  8.3.5.6 Bone Health Supplements
  8.3.6 Historic and Forecasted Market Size By Product type
  8.3.6.1 Genistein
  8.3.6.2 Daidzein
  8.3.6.3 Glutenin.
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
8.4. Western Europe Soy Isoflavones Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Raw-material type
  8.4.4.1 Genetically Modified (GM) Soy
  8.4.4.2 Non-Genetically Modified (Non-GM) Soy
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Soy-Beverages
  8.4.5.2 Functional Foods
  8.4.5.3 Healthcare Products
  8.4.5.4 Dietary Supplements
  8.4.5.5 Menopausal Supplements
  8.4.5.6 Bone Health Supplements
  8.4.6 Historic and Forecasted Market Size By Product type
  8.4.6.1 Genistein
  8.4.6.2 Daidzein
  8.4.6.3 Glutenin.
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
8.5. Asia Pacific Soy Isoflavones Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Raw-material type
  8.5.4.1 Genetically Modified (GM) Soy
  8.5.4.2 Non-Genetically Modified (Non-GM) Soy
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Soy-Beverages
  8.5.5.2 Functional Foods
  8.5.5.3 Healthcare Products
  8.5.5.4 Dietary Supplements
  8.5.5.5 Menopausal Supplements
  8.5.5.6 Bone Health Supplements
  8.5.6 Historic and Forecasted Market Size By Product type
  8.5.6.1 Genistein
  8.5.6.2 Daidzein
  8.5.6.3 Glutenin.
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
8.6. Middle East & Africa Soy Isoflavones Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Raw-material type
  8.6.4.1 Genetically Modified (GM) Soy
  8.6.4.2 Non-Genetically Modified (Non-GM) Soy
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Soy-Beverages
  8.6.5.2 Functional Foods
  8.6.5.3 Healthcare Products
  8.6.5.4 Dietary Supplements
  8.6.5.5 Menopausal Supplements
  8.6.5.6 Bone Health Supplements
  8.6.6 Historic and Forecasted Market Size By Product type
  8.6.6.1 Genistein
  8.6.6.2 Daidzein
  8.6.6.3 Glutenin.
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
8.7. South America Soy Isoflavones Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Raw-material type
  8.7.4.1 Genetically Modified (GM) Soy
  8.7.4.2 Non-Genetically Modified (Non-GM) Soy
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Soy-Beverages
  8.7.5.2 Functional Foods
  8.7.5.3 Healthcare Products
  8.7.5.4 Dietary Supplements
  8.7.5.5 Menopausal Supplements
  8.7.5.6 Bone Health Supplements
  8.7.6 Historic and Forecasted Market Size By Product type
  8.7.6.1 Genistein
  8.7.6.2 Daidzein
  8.7.6.3 Glutenin.
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
 

Global Soy Isoflavones Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 17.2 Bn.

Forecast Period 2024-32 CAGR:

14.19 %

Market Size in 2032:

USD 37.65 Bn.

Segments Covered:

By Raw-material type

  • Genetically Modified (GM)
  • Non-Genetically Modified (Non-GM) Soy

By application

  • Soy-Beverages
  • Functional Foods
  • Healthcare Products
  • Dietary
  • Menopausal
  • Bone Health
  • Others Supplements

By product type

  • Genistein
  • Daidzein
  • Glutenin

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Awareness

Key Market Restraints:

  • Allergic Reactions

Key Opportunities:

  • Innovative Applications

Companies Covered in the report:

  •  Frutarom Health (SoyLife); Archer Daniels Midland Company (ADM); Koninklijke DSM N.V. (DSM); SunOpta Inc.; BASF SE; Cargill Inc., Novogen Limited; E. I. du Pont de Nemours and Company and Other Major Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Soy Isoflavones Market Market Name Market research report?

The forecast period in the Soy Isoflavones Market research report is 2024-2032.

Who are the key players in the Soy Isoflavones Market?

Frutarom Health (SoyLife); Archer Daniels Midland Company (ADM); Koninklijke DSM N.V. (DSM); SunOpta Inc.; BASF SE; Cargill Inc., Novogen Limited; E. I. du Pont de Nemours and Company and Other Major Players.

What are the segments of the Soy Isoflavones Market?

The Soy Isoflavones Market is segmented into By Raw-material type, By application, By product type and region. By Raw-material type, the market is categorized into Genetically Modified (GM) and Non-Genetically Modified (Non-GM) Soy. By application, the market is categorized into Soy-Beverages, Functional Foods, Healthcare Products, Dietary, Menopausal, Bone Health and Others Supplements.By product type, the market is categorized into Genistein, Daidzein and Glutenin. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Soy Isoflavones Market?

Soy isoflavones include the manufacture, sale and usage of isoflavones that are harvested from the soy product and are plant estrogens that possess health-related benefits. These compounds are focused in dietary supplements, functional foods and drinks and can be categorized as hormone modulating compounds for customers, who look for natural solutions for hormonal imbalance, menopause and many more states. They include; improved regard of health and wellness linked to soy isoflavones, high demand for vegetarian products and the changing move towards preventative health measures. Moreover, the market is driven by drivers including consumers’ demand for natural products and growing studies on isoflavone in the management of several diseases.

How Big is the Soy Isoflavones Market?

Soy Isoflavones Market Size is Valued at USD 17.2 Billion in 2023, and is Projected to Reach USD 37.65 Billion by 2032, Growing at a CAGR of 14.19% From 2024-2032.